Description
Recombinant monoclonal antibody to CD9. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the phage display library Nb16-17. This chimeric human antibody was made using the variable domain sequences of the original Alpaca nanobody format, for improved compatibility with existing reagents, assays and techniques.
Target
CD9
Target Alias Names
p24, GIG2, MIC3, MRP-1, TSPAN29, Tetraspanin-29, 5H9 antigen, Leukocyte antigen MIC3, Motility-related protein, Cell growth-inhibiting gene 2 protein
Isotype/Mimetic
IgG1-Fc Fusion
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Methods
Naïve display libraries derived from human B cells, or naïve display libraries from animal B cells or Display libraries from synthetic or natural framework sequences
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-free discovery, Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression